Rheumatoid Arthritis Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

Rheumatoid Arthritis Drugs Market was estimated at $57.92 billion in 2019 and is expected to hit $62.93 billion by 2028, registering a CAGR of 2% from 2022 to 2028. 

Rheumatoid arthritis is a disease that causes pain and inflammation in the joints. It affects individuals of all ages. However, the elderly population is very likely to develop this disease. Symptoms of rheumatoid arthritis include pain, stiffness, tenderness, and swelling of the joint. There is currently no cure for rheumatoid arthritis. However, certain drugs are used to efficiently control the condition of rheumatoid arthritis, including disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and uric acid drugs.

Market Segments

By Drug Class

• Disease-modifying Anti-rheumatic Drugs (DMARDs)
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Uric Acid Drugs
• Others

By Route of Administration

• Oral
• Parenteral

By Sales Channel

• Prescription-based Drugs
• Over-the-counter Drugs

Key Players

The key market players analyzed in the global rheumatoid arthritis drugs market report include Amgen Inc., UCB S.A., Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, and Pfizer Inc. 

Scope of the Report

The research study analyzes the global Rheumatoid Arthritis Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Rheumatoid Arthritis Drugs Market Report

1. What was the Rheumatoid Arthritis Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Rheumatoid Arthritis Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Rheumatoid Arthritis Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.